Accelerant

Accelerant

Risk exchange linking MGAs to capital

Overview

Accelerant operates a technology-driven platform that connects managing general agents (MGAs) and program administrators with risk capital providers, creating a risk exchange for specialty insurance. Its core product provides underwriters with data-driven analytics, insights, and operational resources to improve decision-making and profitability, while enabling the flow of capital to the specialty insurance market. The platform earns fees on the transactions it enables among carriers, reinsurers, institutional investors, MGAs, and program administrators. Unlike traditional brokers or single-vendor platforms, Accelerant focuses on transparency and efficiency in the specialty market by pairing data analytics, risk management tools, and a broad network to connect capital with underwriting opportunities. Its goal is to help the market allocate risk capital more effectively and to support better underwriting outcomes for specialty lines of business.

Funded Recently

About Accelerant

Simplify's Rating
Why Accelerant is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Financial Services

Company Size

501-1,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

2018

Get referred to Accelerant

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $356.9 million, while adjusted EPS beat consensus by 100%.
  • Q2 2026 exchange written premium rose 23% to $1.32 billion, and EBITDA hit 30.6%.
  • August 2026, Accelerant launched ARC AI, AI office hours, and a talent portal.

What critics are saying

  • August 2026, shareholder firms probed the $20.25 price after Altamont’s 82% voting control.
  • The merger needs insurance approvals and shareholder consent; closing slips into first-half 2027.
  • Going private ends NYSE liquidity and concentrates fate with Thoma Bravo and Altamont.

What makes Accelerant unique

  • August 2026, Accelerant’s ARX exchange links MGAs to risk capital and underwriting data.
  • July 2026, Incline expanded to front over $500 million annual U.S. specialty premium.
  • August 2026, Thoma Bravo said Accelerant’s data-fueled platform becomes specialty insurance infrastructure.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1.1B

Above

Industry Average

Funded Over

5 Rounds

Buyout funding comparison data is currently unavailable. We're working to provide this information soon!
Buyout Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Unlimited Paid Time Off

Remote Work Options

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

3%
MarketBeat
Aug 14th, 2026
Accelerant (NYSE:ARX) sees strong trading volume on better-than-expected earnings.

Accelerant (NYSE:ARX) sees strong trading volume on better-than-expected earnings. August 14, 2026 Key points. * Accelerant reported better-than-expected quarterly results, earning $0.32 per share versus the $0.16 consensus estimate on revenue of $356.9 million. Trading volume rose 150% to nearly 5 million shares. * Thoma Bravo agreed to take Accelerant private in an all-cash deal valued at more than $4 billion, offering shareholders $20.25 per share and serving as the main catalyst for the stock's recent gains. * Analysts largely view the shares as fairly valued near the transaction price, with a consensus "Hold" rating and $18.73 price target. Shareholder law firms are investigating whether the deal price was fair, while insiders have sold more than 1.2 million shares over the past 90 days. * MarketBeat previews the top five stocks to own by September 1st. Accelerant Holdings (NYSE:ARX - Get Free Report) saw strong trading volume on Friday after the company announced better than expected quarterly earnings. Approximately 4,954,463 shares were traded during trading, an increase of 150% from the previous session's volume of 1,980,874 shares.The stock last traded at $19.5550 and had previously closed at $19.51. The technology company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.16. The company had revenue of $356.90 million for the quarter. Accelerant had a positive return on equity of 49.99% and a negative net margin of 135.47%. Here are the key news stories impacting Accelerant this week: * Positive Sentiment: Thoma Bravo agreed to take Accelerant Holdings private in an all-cash transaction valued at more than $4 billion, offering shareholders $20.25 per share. The buyout price is the primary catalyst behind the stock's sharp advance and provides a potential near-term valuation anchor. Reuters Thoma Bravo acquisition article * Positive Sentiment: Accelerant's second-quarter earnings exceeded expectations: adjusted earnings were $0.32 per share versus a $0.16 consensus estimate, while revenue reached $356.9 million. The performance was supported by premium growth, higher fee revenue and stronger Exchange Services results. Accelerant second-quarter earnings report * Neutral Sentiment: Citizens JMP reaffirmed its "market perform" rating, while William Blair lowered Accelerant from "outperform" to "market perform." These actions suggest analysts see limited incremental upside beyond the transaction price rather than a major change in the company's operating outlook. William Blair rating change * Negative Sentiment: Several law firms are investigating whether Accelerant's board obtained a fair price for public shareholders and whether conflicts involving controlling shareholder Altamont Capital Partners affected the Thoma Bravo transaction. Such reviews could create deal uncertainty or encourage a higher offer, although no wrongdoing has been established. Ademi shareholder investigation Analyst Ratings changes. A number of analysts have weighed in on the stock. William Blair lowered shares of Accelerant from an "outperform" rating to a "market perform" rating in a research note on Thursday. Wells Fargo & Company lowered their target price on Accelerant from $17.00 to $16.00 and set an "overweight" rating on the stock in a report on Thursday, July 9th. Weiss Ratings raised shares of Accelerant from a "sell (e+)" rating to a "sell (d-)" rating in a report on Tuesday, August 4th. Citigroup downgraded Accelerant from an "outperform" rating to a "market perform" rating in a research report on Thursday. Finally, Royal Bank Of Canada lowered shares of Accelerant from an "outperform" rating to a "sector perform" rating in a research report on Friday. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Accelerant presently has a consensus rating of "Hold" and an average price target of $18.73. Discover more Earnings screener tool Market cap calculator Options profit calculator Insider buying and selling. In related news, COO Matthew David Sternberg sold 17,568 shares of the company's stock in a transaction on Monday, July 27th. The shares were sold at an average price of $14.64, for a total transaction of $257,195.52. Following the sale, the chief operating officer owned 596,482 shares of the company's stock, valued at $8,732,496.48. This represents a 2.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Francis James Oneill sold 89,219 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $12.41, for a total transaction of $1,107,207.79. Following the sale, the insider owned 6,369,290 shares in the company, valued at $79,042,888.90. This represents a 1.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,216,240 shares of company stock worth $16,146,480. Insiders own 66.59% of the company's stock. Institutional investors weigh in on Accelerant. A number of institutional investors and hedge funds have recently modified their holdings of the business. State of Wyoming bought a new stake in shares of Accelerant during the first quarter worth $28,000. Quarry LP bought a new position in shares of Accelerant during the third quarter valued at approximately $40,000. PNC Financial Services Group Inc. bought a new stake in Accelerant during the 3rd quarter valued at $42,000. Royal Bank of Canada boosted its position in Accelerant by 50.3% during the first quarter. Royal Bank of Canada now owns 7,729 shares of the technology company's stock valued at $103,000 after purchasing an additional 2,585 shares in the last quarter. Finally, CWM LLC bought a new stake in shares of Accelerant in the 4th quarter valued at about $109,000. Accelerant stock up 0.2%. The company's fifty day simple moving average is $13.27 and its 200-day simple moving average is $13.15. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market capitalization of $4.27 billion and a PE ratio of -2.81. About Accelerant. Aeroflex Holding Corp. (Aeroflex Holding) is a provider of radio frequency (RF) and microwave integrated circuits, components and systems used in the design, development and maintenance of wireless communication systems. The Company's solutions include microelectronic components and test and measurement equipment used by companies in the space, avionics and defense; commercial wireless communications, and medical and other markets. Its products include a range of RF, microwave and millimeter wave microelectronic components, integrated circuits (ICs), and analog and mixed-signal devices. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Accelerant, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accelerant wasn't on the list. While Accelerant currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Global Legal Post
Aug 13th, 2026
Paul Hastings, Goodwin, Sidley and Skadden among firms advising on Thoma Bravo's $4bn Accelerant take private.

Paul Hastings, Goodwin, Sidley and Skadden among firms advising on Thoma Bravo's $4bn Accelerant take private. Firms including Maples Group, Walkers, Conyers Dill & Pearman and Ropes & Gray also on deal 13 August 2026 Paul Hastings, Goodwin Procter, Sidley Austin and Skadden were among the firms called in to advise on investment firm Thoma Bravo's more than $4bn deal to take speciality insurance marketplace Accelerant private. Paul Hastings is acting as US legal counsel to Accelerant, while Sidley Austin is serving as special insurance counsel and Maples Group is serving as Cayman Islands legal counsel for the company. Meanwhile, Goodwin Procter is serving as legal counsel to Thoma Bravo, Skadden is providing special insurance counsel and Walkers is serving as Cayman Islands legal counsel. Conyers Dill & Pearman is serving as legal counsel to a special committee representing Accelerant, while Ropes & Gray is serving as legal counsel to Altamont Capital Partners, Accelerant's largest investor. Advertisement Thoma Bravo is paying $20.25 per share in cash for Accelerant, a 49% premium on the company's closing share price on Wednesday (12 August). The deal values Accelerant at more than $4bn. Altamont and Accelerant's founders intend to retain equity ownership alongside Thoma Bravo, with the terms still to be finalised. The deal is expected to close in the first half of next year, subject to customary closing conditions and regulatory approvals. The Paul Hastings team on the deal was led by global M&A co-chair Eric Schiele and securities and capital markets global co-chair Colin Diamond, alongside partners Andrew Goodman, Dmitriy Molchanov and Kirk Lipsey. They were supported by insurance regulatory partner Sanjiv Tata; employee benefits partners Sasha Belinkie and Dan Stellenberg; antitrust partners Sally Evans, Salome Cisnal de Ugarte, Josh Soven and Gail Levine; finance partner Tracey Chenoweth; tax partners Andrew Davis and Jenny Doak; and technology transactions co-chair Sarah Gagan. The Sidley team advising Accelerant included capital markets partner Samir Gandhi in New York and insurance partners Tony Ribaudo and Sara Africano in Chicago and James Phythian-Adams in London. LAW OVER BORDERS COMPARATIVE GUIDES Arbitration Law Guide The Law Over Borders Comparative Guide to Arbitration provides a comprehensive understanding of the current complexities of international arbitration... | 1yr. Meanwhile, the Goodwin team advising Thoma Bravo was led by private equity partners David Johanson and Matthew Cognetti and global M&A chair Joshua Zachariah and M&A partner James Ding. The team have previously advised Thoma Bravo on deals including its $2.8bn acquisition of Ping Identity and its $1.8bn acquisition of NextGen Healthcare. The Skadden team advising Thoma Bravo includes insurance and M&A partner Elena Coyle (New York); financial institutions counsels Matthew Roberts (New York), Caroline Jaffer (London) and Cheryl Bunevich (New York); corporate counsel François Barrière (Paris); and tax partner Jared Binstock (Washington DC). The Walkers team included corporate partners Jason Allison, Hugh Anderson and Michael Beck, insolvency and dispute resolution partner Barnaby Gowrie, insurance partner Gary Harris and regulatory partner Juliana Tan. Jeff Radke, chairman and CEO of Accelerant, said: "Accelerant has been building the preeminent specialty insurance marketplace since our founding in 2018. Returning to private ownership with Thoma Bravo's technology and software expertise, coupled with its vast financial and strategic resources, will enable us to make investments that further position our unique, data-fuelled platform to be the rails on which specialty insurance runs."

PR Newswire
Aug 13th, 2026
Shareholder alert: Ademi LLP investigates whether Accelerant holdings is obtaining a fair price for public shareholders.

Shareholder alert: Ademi LLP investigates whether Accelerant holdings is obtaining a fair price for public shareholders. Aug 13, 2026, 10:48 ET MILWAUKEE, Aug. 13, 2026 /PRNewswire/ - Ademi LLP is investigating Accelerant (NYSE: ARX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Thoma Bravo. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. Accelerant shareholders may elect to receive $20.25 per share in cash in an all-cash transaction with an enterprise value of more than $4 billion. Accelerant insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for Accelerant by imposing a significant penalty if Accelerant accepts a competing bid. We are investigating the conduct of the Accelerant board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Ademi LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 SOURCE Ademi LLP

StockTitan
Aug 13th, 2026
Thoma Bravo to acquire Accelerant for $4B in 49% premium buyout deal

Thoma Bravo has agreed to acquire Accelerant, a data-driven specialty insurance marketplace, in an all-cash transaction with an enterprise value exceeding $4 billion. Accelerant shareholders will receive $20.25 per share, representing a 49% premium to the 12 August 2026 closing price. The deal has been unanimously approved by Accelerant's board following recommendation from a special committee of independent directors. Entities affiliated with Altamont Capital Partners, holding approximately 82% of voting rights, have agreed to support the transaction. The acquisition is expected to close in the first half of 2027, subject to shareholder approval and regulatory clearances. Upon completion, Accelerant will become private and delist from the New York Stock Exchange. Altamont Capital Partners and Accelerant's founders intend to retain equity ownership alongside Thoma Bravo.

MarketBeat
Jul 28th, 2026
Accelerant (NYSE:ARX) CEO Jeffrey Radke sells 95,223 shares of stock.

Accelerant (NYSE:ARX) CEO Jeffrey Radke sells 95,223 shares of stock. July 28, 2026 Key points. * CEO Jeffrey Radke sold 95,223 Accelerant shares at an average price of $14.60, generating approximately $1.39 million. The Rule 10b5-1 transaction reduced his stake by 0.34%, leaving him with 27.75 million shares. * Accelerant reported quarterly EPS of $0.17, beating estimates by $0.01, while revenue rose 53.5% year over year to $273.2 million. Despite positive return on equity, the company posted a negative net margin of 135.47%. * ARX traded near $14.59, below the analyst consensus target of $18.60. Analysts maintain a "Moderate Buy" consensus, although ratings range from "Sell" to "Outperform" or "Overweight." * MarketBeat previews the top five stocks to own by August 1st. Accelerant Holdings (NYSE:ARX - Get Free Report) CEO Jeffrey Radke sold 95,223 shares of the company's stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $14.60, for a total transaction of $1,390,255.80. Following the transaction, the chief executive officer owned 27,751,939 shares in the company, valued at approximately $405,178,309.40. This trade represents a 0.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Accelerant stock performance. ARX stock traded down $0.02 during trading on Tuesday, reaching $14.59. The company had a trading volume of 8,698,313 shares, compared to its average volume of 1,499,303. The firm has a 50-day simple moving average of $14.08 and a 200-day simple moving average of $13.34. The company has a market cap of $3.18 billion and a price-to-earnings ratio of -2.09. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.61 and a current ratio of 1.61. Accelerant Holdings has a twelve month low of $9.18 and a twelve month high of $30.48. Accelerant (NYSE:ARX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The technology company reported $0.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. Accelerant had a negative net margin of 135.47% and a positive return on equity of 49.99%. The business had revenue of $273.20 million for the quarter. The business's revenue for the quarter was up 53.5% on a year-over-year basis. As a group, sell-side analysts expect that Accelerant Holdings will post 0.73 earnings per share for the current year. Institutional trading of Accelerant. A number of hedge funds have recently modified their holdings of ARX. Militia Capital Management LLC purchased a new position in Accelerant during the first quarter valued at approximately $2,004,000. Royal Bank of Canada grew its stake in shares of Accelerant by 50.3% during the 1st quarter. Royal Bank of Canada now owns 7,729 shares of the technology company's stock worth $103,000 after purchasing an additional 2,585 shares during the period. The Manufacturers Life Insurance Company purchased a new position in shares of Accelerant during the 1st quarter valued at approximately $137,000. SummitTX Capital L.P. lifted its stake in shares of Accelerant by 11.0% in the 1st quarter. SummitTX Capital L.P. now owns 62,999 shares of the technology company's stock valued at $842,000 after purchasing an additional 6,219 shares during the period. Finally, Entropy Technologies LP purchased a new stake in Accelerant during the first quarter worth $239,000. Analyst upgrades and downgrades. Several research firms have weighed in on ARX. Citizens Jmp dropped their price target on Accelerant from $20.00 to $17.00 and set a "market outperform" rating on the stock in a research note on Monday, April 13th. UBS Group set a $16.00 target price on Accelerant in a report on Thursday, May 21st. BMO Capital Markets upped their target price on Accelerant from $16.50 to $17.00 and gave the company an "outperform" rating in a research report on Tuesday, June 16th. Weiss Ratings lowered shares of Accelerant from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday, July 20th. Finally, Piper Sandler lifted their price objective on shares of Accelerant from $18.00 to $19.00 and gave the company an "overweight" rating in a research note on Tuesday, May 26th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Accelerant currently has an average rating of "Moderate Buy" and a consensus target price of $18.60. Discover more Stock Screener Tool Stock Market Holidays Market Cap Calculator About Accelerant. Aeroflex Holding Corp. (Aeroflex Holding) is a provider of radio frequency (RF) and microwave integrated circuits, components and systems used in the design, development and maintenance of wireless communication systems. The Company's solutions include microelectronic components and test and measurement equipment used by companies in the space, avionics and defense; commercial wireless communications, and medical and other markets. Its products include a range of RF, microwave and millimeter wave microelectronic components, integrated circuits (ICs), and analog and mixed-signal devices. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Accelerant, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accelerant wasn't on the list. While Accelerant currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Recently Posted Jobs

Sign up to get curated job recommendations

Accelerant is Hiring for 19 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →